Valuation: Medicure Inc.

Market Cap 26.09M 18.81M 16.2M 15.34M 13.91M 1.8B 26.22M 182M 70.08M 914M 70.63M 69.08M 2.89B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 23.15M 16.69M 14.38M 13.61M 12.34M 1.59B 23.26M 162M 62.17M 811M 62.66M 61.29M 2.56B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.40%
Current month-1.96%
1 month+83.82%
3 months+140.38%
6 months+163.16%
Current year+119.30%
1 week 1.38
Extreme 1.38
2.74
1 month 1.28
Extreme 1.28
2.74
Current year 0.85
Extreme 0.85
2.74
1 year 0.85
Extreme 0.85
2.74
3 years 0.63
Extreme 0.63
2.74
5 years 0.63
Extreme 0.63
2.74
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 15/09/1997
Director of Finance/CFO 48 15/07/2011
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 79 15/09/1997
Director/Board Member 93 28/02/2000
Director/Board Member 56 22/01/2013
Date Insider Type Main position Quantity % Market Cap. Importance
30/7/26 Option

Chief Technology Officer

-20,000 0.1916%
28/3/25 Option

Chief Technology Officer

7,500 0.0719%
28/3/25 Option

Director

7,200 0.0690%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%0.00%+150.00%+61.29% 18.81M
-2.11%-1.68%+43.40%+95.58% 66.93B
+1.01%-0.78%+35.20%+75.75% 61.97B
-2.68%+1.31%-11.61%+374.39% 28.26B
+4.55%+1.36%+26.52%+17.28% 24.59B
+1.59%-0.28%+0.51%-13.56% 24.3B
+1.03%-1.59%+18.44%-22.25% 19.41B
-3.03%-2.29%+181.72%+333.47% 16.77B
+3.44%-1.88%-5.46%+547.21% 14.18B
+4.33%+5.90%-3.38%+858.12% 14B
Average +0.84%-2.65%+43.53%+232.73% 27.04B
Weighted average by Cap. +0.27%-2.83%+32.19%+172.70%

Financials

2024 2025
Net sales 21.91M 15.79M 13.61M 12.88M 11.68M 1.51B 22.02M 153M 58.84M 768M 59.31M 58.01M 2.43B 28.86M 20.8M 17.92M 16.97M 15.38M 1.99B 29M 202M 77.5M 1.01B 78.12M 76.4M 3.19B
Net income -1.04M -749K -645K -611K -554K -71.55M -1.04M -7.26M -2.79M -36.4M -2.81M -2.75M -115M -7.1M -5.12M -4.41M -4.17M -3.78M -489M -7.13M -49.57M -19.06M -249M -19.21M -18.79M -786M
Net Debt -6.32M -4.55M -3.92M -3.71M -3.37M -435M -6.35M -44.12M -16.97M -221M -17.1M -16.73M -699M -2.94M -2.12M -1.83M -1.73M -1.57M -203M -2.96M -20.56M -7.91M -103M -7.97M -7.8M -326M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
11/09/26 CAD 2.500 +0.40% 225
10/09/26 CAD 2.490 -3.86% 9,800
09/09/26 CAD 2.590 0.00% 1,000
08/09/26 CAD 2.590 +3.60% 3,114
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!